More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Researchers sought to determine the effects of high body mass index and low physical activity levels on incidence of subsequent neoplasms in survivors of childhood cancer. Obesity was associated with ...

In the first part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, describes the US payer ecosystem’s ...

Childhood obesity rates are rising and global figures don't make for easy reading. The World Health Organization (WHO) ...

This lawsuit may look like a business dispute on the surface. But underneath, it’s about something much more important: the right of patients to receive personalized, affordable care.

In Europe, they relax and take time to allow the food to digest. Here, fast food is king. Even food-related names denote speed: In-N-Out Burgers, DoorDash and Sonic. That last one? You park and they ...

OPINION The cruel costs of denying anti-obesity medication Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs in the form ...

From our earliest days in medical school, we learned that treatment requires a patient’s informed consent. What is less often taught is how to obtain that consent in a manner that withstands legal ...

With a first-in-class approval in China, Eli Lilly’s GLP-1 development engine has delivered yet again on the obesity front—although local biopharma outfit Innovent Biologics will be the one to ...

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare costs. Lifestyle changes and improved diets are critical but often ...